Las Vegas. NV, Nov. 18, 2015 (GLOBE NEWSWIRE) -- EQ Labs, Inc. ("EQ." or "the Company") (OTC.BB: EQLB), is pleased to update you on the expanding role of Timothy Mosley aka Timbaland in our market launch. Mr. Mosley will be the principal spokesman for our lead product "Last Shot". This will include his support through social media, national commercials, advertising and endorsement of our product.
"We are excited to have Timbaland Mosley as our new Equity Partner for, "Last Shot", the 3 in 1 can beverage. "Cranberry flavor helps Energize, Hydrate and Detox its consumers" states Mo Owens, CEO of EQ. "This product is being made available to the retail customers through bars, night clubs, hotel resorts and golf courses throughout the Las Vegas area throughout the end of this year." Mr. Owens further stated "There are roughly 150,000 rooms with mini bars in Las Vegas. With 10% of the mini bars in the Las Vegas rooms alone and a major distribution effort to assist us with the Las Vegas roll out, revenue from those venues alone could potential exceed $6 million." Owens also stated" the ground work put into this marketing campaign over the past years is now coming to fruition.
Timothy Moseley proudly states "Mo and I have major plans for EQ in the month to come, we've been working diligently on our new partnership to bring my resources and venue for the introduction of LastShot cranberry flavor Cold Beverage to North American market. I am excited to be hands on project like this".
About EQ Lab, Inc.:
EQ Labs, Inc is a leader in the marketing and development of measured product release devices for the retail market. Its products will be sold through major retail stores, casinos, beverage distribution outlets and chains throughout the US. Leading products include Last Shot 3 in 1 Hangover Protection Cranberry Cold Beverage, 5 Cal/2 Carbs dietary supplement energize *hydrate* detox.
Safe Harbor:
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements generally can be identified by phrases such as EQ Labs, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new business opportunities and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report, our quarterly reports and other periodic reports filed from time-to-time with the OTC Markets.